Abbott Laboratories

Abbott Laboratories ROE

The Return on Equity (ROE) of Abbott Laboratories (ABT) as of Nov 17, 2026 is 12.51 %. In the previous year, Return on Equity (ROE) was 28.12 % — a change of -55.49% (lower).

ROE

12.51 %

YoY

-55.49%

Last updated:

In 2025, Abbott Laboratories's return on equity (ROE) was 12.51 %, a -55.49% increase from the 28.12 % ROE in the previous year.

The Abbott Laboratories ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
7.76 USD
Jan 1, 2019
11.86 USD
Jan 1, 2020
13.71 USD
Jan 1, 2021
19.75 USD
Jan 1, 2022
18.90 USD
Jan 1, 2023
14.83 USD
Jan 1, 2024
28.12 USD
Jan 1, 2025
12.51 USD
The Abbott Laboratories ROE history
YEARROEYoY
12.51 %-55.49%
28.12 %+89.66%
14.83 %-21.55%
18.90 %-4.31%
19.75 %+44.05%
13.71 %+15.61%
11.86 %+52.88%
7.76 %+402.50%
1.54 %-77.35%
6.82 %-67.31%
20.85 %+96.53%
10.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Abbott Laboratories Stock analysis

What does Abbott Laboratories do? Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories is one of the most popular companies on Eulerpool.

ROE Details

Decoding Abbott Laboratories's Return on Equity (ROE)

Abbott Laboratories's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Abbott Laboratories's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Abbott Laboratories's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Abbott Laboratories’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Abbott Laboratories stock

Return on Equity (ROE) of Abbott Laboratories is 12.51 % in 2025.

Return on Equity (ROE) of Abbott Laboratories changed from 28.12 % to 12.51 %, representing a -55.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Abbott Laboratories since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Abbott Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Abbott Laboratories

All Key Metrics — Abbott Laboratories